/Companies

Anthera Pharmaceuticals

Defunct

Hayward, US · Delaware corporation · 2 known investors

Find your way into Anthera Pharmaceuticals

Sign up to see every warm intro you have to Anthera Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anthera Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Developing products for diseases associated with inflammation. (NASDAQ: ANTH)

Founders & leadership

ML
May LiuExecutive

Investors · 2

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 1 round · 2017

▶$15MraisedJan 2018 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • May LiuExecutive Officer
Offering amount
$15M
Amount sold
$15M
Sales commissions
$1.1M
Placement agents
Piper Jaffray & Co.
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Anthera Pharmaceuticals went on to found or lead other companies.

Frequently asked questions

What does Anthera Pharmaceuticals do?
Developing products for diseases associated with inflammation. (NASDAQ: ANTH)
Who are Anthera Pharmaceuticals's investors?
Anthera Pharmaceuticals's investors include Pappas Capital, Sofinnova Ventures.
How much funding has Anthera Pharmaceuticals raised?
Anthera Pharmaceuticals has disclosed $15M raised across 1 round.
Where is Anthera Pharmaceuticals headquartered?
Anthera Pharmaceuticals is headquartered in Hayward, US.